Genzyme (NASDAQ: GENZ) is open to selling off some of its noncore businesses, CEO Henri Termeer (photo) said Tuesday at the Health Blog HQ, according to the Wall Street Journal Health Blog. The company will brief analysts and investors about its more peripheral businesses at a May 6 meeting in Boston, when it also will reveal details about its individual operations. Report